Cargando…
A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches
OBJECTIVES: This evaluation assesses the quantity, uniqueness, and innovative nature of the past 20 years of Rx-to-OTC (RTO) switches, where a current prescription (Rx) product is reclassified for over-the-counter (OTC) status. Broadening access to more OTC drugs with well-established safety and eff...
Autores principales: | Fisher, Matt, Rawal, Kapil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400472/ https://www.ncbi.nlm.nih.gov/pubmed/37357243 http://dx.doi.org/10.1007/s43441-023-00547-9 |
Ejemplares similares
-
Prescription to over-the-counter switches in the United States
por: Chang, Jongwha, et al.
Publicado: (2016) -
Prescription Drugs Marketed in the United States Should Be Approved by the FDA
por: Shepherd, Marvin
Publicado: (2003) -
Promises and perils of the FDA's over-the-counter naloxone reclassification
por: Zhu, David T., et al.
Publicado: (2023) -
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
por: Tamatam, Rekha, et al.
Publicado: (2023) -
FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
por: Idrees, Zarwa, et al.
Publicado: (2022)